Cat. No.: OCKT-2603-CXX-017
Description: The human hepatocellular carcinoma organoid kit is composed of hepatocellular carcinoma organoid basal medium A, supplement B, and supplement C. It is designed to efficiently construct human hepatocellular carcinoma organoids.
Price: Inquiry
Datasheet: Datasheet
| Size | 100 mL/500 mL |
| Advantages | Hepatocellular carcinoma organoids effectively simulate the liver tumor microenvironment, supporting the observation of cancer cell growth. They are a valuable tool for tracking cellular responses to drugs and for screening therapeutic efficacy and toxicity. |
| Species | Human |
| Components | Hepatocellular Carcinoma Organoid Basal Medium A; Culture Supplement B & C. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Hepatocellular Carcinoma Organoid Basal Medium A: 4°C, 1 year; Culture Supplement B & C: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Culture Supplement B & C: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.
